Skip to main content
Top
Published in: Osteoporosis International 7/2011

01-07-2011 | Original Article

The relationship of fetuin-A and lactoferrin with bone mass in elderly women

Authors: L. Chailurkit, A. Kruavit, R. Rajatanavin, B. Ongphiphadhanakul

Published in: Osteoporosis International | Issue 7/2011

Login to get access

Abstract

Summary

The relationships of fetuin-A and lactoferrin to bone-related phenotypes were investigated in elderly women. Fetuin-A was associated not only with bone mineral density (BMD) but also with bone resorption marker suggesting an influence of fetuin-A on osteoclasts.

Introduction

The aim of this study is to investigate the relationship of bone-related phenotypes in elderly women with circulating fetuin-A and lactoferrin.

Methods

Eighty-two elderly women were studied. Serum fetuin-A, lactoferrin, C-terminal telopeptide of type I collagen (CTx), total procollagen type 1 amino-terminal propeptide, and plasma intact parathyroid hormone (PTH) were analyzed. BMD of the lumbar spine at L2–4 and at the femoral neck was measured.

Results

Serum fetuin-A was significantly associated with L2–4 BMD (r = 0.23, P < 0.05). After controlling for age and body weight, the association remained statistically significant. There was a significant association between serum fetuin-A and serum CTx (r = −0.37, P < 0.001). The association between fetuin-A and L2–4 BMD no longer existed after controlling for serum CTx. There were positive associations of circulating lactoferrin with plasma PTH (r = 0.24, P < 0.05) and serum CTx (r = 0.26, P < 0.05). No association between serum lactoferrin and BMD at the lumbar spine or femoral neck was detected.

Conclusions

Circulating fetuin-A is related to bone mass and bone resorption markers in elderly women. Lactoferrin, in contrast, is associated only with bone resorption markers.
Literature
1.
go back to reference Price PA, Toroian D, Lim JE (2009) Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem 284:17092–17101PubMedCrossRef Price PA, Toroian D, Lim JE (2009) Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem 284:17092–17101PubMedCrossRef
2.
go back to reference Ix JH, Wassel CL, Bauer DC, Toroian D, Tylavsky FA, Cauley JA, Harris TB, Price PA, Cummings SR, Shlipak MG (2009) Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study. J Bone Miner Res 24:514–521PubMedCrossRef Ix JH, Wassel CL, Bauer DC, Toroian D, Tylavsky FA, Cauley JA, Harris TB, Price PA, Cummings SR, Shlipak MG (2009) Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study. J Bone Miner Res 24:514–521PubMedCrossRef
3.
go back to reference Cornish J, Callon KE, Naot D et al (2004) Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145:4366–4374PubMedCrossRef Cornish J, Callon KE, Naot D et al (2004) Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145:4366–4374PubMedCrossRef
4.
go back to reference Guo HY, Jiang L, Ibrahim SA, Zhang L, Zhang H, Zhang M, Ren FZ (2009) Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats. J Nutr 139:958–964PubMedCrossRef Guo HY, Jiang L, Ibrahim SA, Zhang L, Zhang H, Zhang M, Ren FZ (2009) Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats. J Nutr 139:958–964PubMedCrossRef
5.
go back to reference World Health Organization (WHO) Study Group on Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis; World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group Geneva; World Health Organization, p 1129 World Health Organization (WHO) Study Group on Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis; World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group Geneva; World Health Organization, p 1129
6.
go back to reference Chailurkit L, Piaseu N, Rajatanavin R (2002) Influence of normal ageing on mechanism of bone loss in women and men in Bangkok. J Med Assoc Thai 85:915–921PubMed Chailurkit L, Piaseu N, Rajatanavin R (2002) Influence of normal ageing on mechanism of bone loss in women and men in Bangkok. J Med Assoc Thai 85:915–921PubMed
7.
go back to reference Reinehr T, Roth CL (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93:4479–4485PubMedCrossRef Reinehr T, Roth CL (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93:4479–4485PubMedCrossRef
8.
go back to reference Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG (2008) Fetuin-A and incident diabetes mellitus in older persons. JAMA 300:182–188PubMedCrossRef Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG (2008) Fetuin-A and incident diabetes mellitus in older persons. JAMA 300:182–188PubMedCrossRef
9.
go back to reference Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555–2562PubMedCrossRef Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555–2562PubMedCrossRef
10.
go back to reference Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Haring HU, Stefan N (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3:e1765PubMedCrossRef Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Haring HU, Stefan N (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3:e1765PubMedCrossRef
11.
go back to reference Coen G, Ballanti P, Silvestrini G, Mantella D, Manni M, Di Giulio S, Pisano S, Leopizzi M, Di Lullo G, Bonucci E (2009) Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch 454:263–271PubMedCrossRef Coen G, Ballanti P, Silvestrini G, Mantella D, Manni M, Di Giulio S, Pisano S, Leopizzi M, Di Lullo G, Bonucci E (2009) Immunohistochemical localization and mRNA expression of matrix Gla protein and fetuin-A in bone biopsies of hemodialysis patients. Virchows Arch 454:263–271PubMedCrossRef
12.
go back to reference Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR (1999) Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14:1302–1309PubMedCrossRef Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR (1999) Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14:1302–1309PubMedCrossRef
13.
go back to reference Lorget F, Clough J, Oliveira M, Daury MC, Sabokbar A, Offord E (2002) Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 296:261–266PubMedCrossRef Lorget F, Clough J, Oliveira M, Daury MC, Sabokbar A, Offord E (2002) Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 296:261–266PubMedCrossRef
14.
go back to reference Blais A, Malet A, Mikogami T, Martin-Rouas C, Tome D (2009) Oral bovine lactoferrin improves bone status of ovariectomized mice. Am J Physiol Endocrinol Metab 296:E1281–E1288PubMedCrossRef Blais A, Malet A, Mikogami T, Martin-Rouas C, Tome D (2009) Oral bovine lactoferrin improves bone status of ovariectomized mice. Am J Physiol Endocrinol Metab 296:E1281–E1288PubMedCrossRef
15.
go back to reference Ward PP, Mendoza-Meneses M, Cunningham GA, Conneely OM (2003) Iron status in mice carrying a targeted disruption of lactoferrin. Mol Cell Biol 23:178–185PubMedCrossRef Ward PP, Mendoza-Meneses M, Cunningham GA, Conneely OM (2003) Iron status in mice carrying a targeted disruption of lactoferrin. Mol Cell Biol 23:178–185PubMedCrossRef
16.
go back to reference Misra S, Fu AA, Anderson JL, Glockner JF, McKusick MA, Bjarnason H, Woodrum DA, Mukhopadhyay D (2008) Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol 19:1477–1482PubMedCrossRef Misra S, Fu AA, Anderson JL, Glockner JF, McKusick MA, Bjarnason H, Woodrum DA, Mukhopadhyay D (2008) Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure. J Vasc Interv Radiol 19:1477–1482PubMedCrossRef
Metadata
Title
The relationship of fetuin-A and lactoferrin with bone mass in elderly women
Authors
L. Chailurkit
A. Kruavit
R. Rajatanavin
B. Ongphiphadhanakul
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 7/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1439-3

Other articles of this Issue 7/2011

Osteoporosis International 7/2011 Go to the issue